Europe looks to shore up medicines supply amid shortages
Drug shortages have impacted both the US and Europe in recent years, and with Europe seeing a shortage in antibiotics and insulin, member states are looking for solutions to improve the medicine supply.
In a four-page document, 19 EU member states say that shortages have been steadily increasing, with 75% of surveyed countries reporting last year that shortages of pharmaceuticals had worsened compared to the previous year. The document gives several reasons for the shortages, such as increases in demand, manufacturing and quality issues, factory closures and supply chain bottlenecks, among others.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 170,200+ biopharma pros reading Endpoints daily — and it's free.